RecruitingNot Applicable

International Headache Registry Study

China200,000 participantsStarted 2021-07-12

Plain-language summary

In the International Headache and Vertigo Registration Study, patients aged 4-99 years with headache (primary headache and secondary headache such as migraine and tension type headache), vertigo (vertigo diseases such as vestibular migraine) and chronic pain (fibromyalgia and other diseases) were collected. The biomarkers, imaging features, right-to-left shunt of the heart (lung), genetic characteristics, treatment, and outcome (in relation to other diseases) of headache-related diseases were studied, and long-term follow-up was planned.

Who can participate

Age range4 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
✓. Male or female participants ages 4 to 99 years, inclusive, at Visit 1.
✓. Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches, and patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).

Exclusion criteria

✕. Patients who were unable to complete scales such as headache diary.
✕. Patients denied or unable to be admitted for long-term follow-up.

What they're measuring

Days of Migraine

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years

Moderate / Severe Headache Days

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years

Migraine Attack

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years

Trial details

NCT IDNCT05418218

SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2082-12-31

Contact for this trial

Kaiming Liu, Doctor

+8615068862055 2314411@zju.edu.cn

View on ClinicalTrials.gov More Headache Disorders, Primary trials

Plain-language summary

Who can participate

Age range4 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Written informed consent and participant privacy information (eg, Written Authorization for Use and Release of Health and Research Study Information) obtained from the participant prior to initiation of any study-specific procedures.
✓. Male or female participants ages 4 to 99 years, inclusive, at Visit 1.
✓. Headache patients meeting the diagnostic criteria for ICHD-3, including primary headaches such as migraine and tension tension-type headaches, secondary headaches, and patients who meet the headache diagnosis in the ICHD-3 appendix (including vestibular migraine).

Exclusion criteria

✕. Patients who were unable to complete scales such as headache diary.
✕. Patients denied or unable to be admitted for long-term follow-up.

What they're measuring

Days of Migraine

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years

Moderate / Severe Headache Days

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years

Migraine Attack

Timeframe: Medium term: within 6 months after initial diagnosis; long term: 60 years